Pomegranate juice protects nitric oxide against oxidative destruction and enhances the biological actions of nitric oxide

Nitric Oxide - Biology and Chemistry

Volumn 15, Issue 2, 2006, Pages 93-102

  Ignarro, Louis J ^a   Byrns, Russell E ^a   Sumi, Daigo ^a   de Nigris, Filomena ^b   Napoli, Claudio ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Antioxidant activity; Flavonoids; Nitric oxide; Polyphenols; Vascular smooth muscle proliferation

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; EFLORNITHINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HERBACEOUS AGENT; NITRIC OXIDE; SUPEROXIDE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; BLUEBERRY; CATALYSIS; CELL GROWTH; CELL PROLIFERATION; CHEMOLUMINESCENCE; CONTROLLED STUDY; DILUTION; FRUIT JUICE; GRAPE JUICE; GROWTH INHIBITION; NONHUMAN; OXIDATION; OXIDATIVE STRESS; POMEGRANATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY ARTERY; RAT; RED WINE; SMOOTH MUSCLE FIBER; UPREGULATION; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANTIOXIDANTS; BEVERAGES; CATALYSIS; CATTLE; CELL PROLIFERATION; GENE EXPRESSION; MUSCLE CELLS; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OXIDATION-REDUCTION; PROMOTER REGIONS (GENETICS); PULMONARY ARTERY; PUNICACEAE; RATS; UP-REGULATION;

BOS TAURUS; LYTHRACEAE; VACCINIUM; VITIS LABRUSCA;

EID: 33746795022     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.niox.2006.03.001     Document Type: Article

References (47)

1. Aviram M., Dornfeld L., Kaplan M., Coleman R., Gaitini D., Nitecki S., Hofman A., Rosenblat M., Volkova N., Presser D., Attias J., Hayek T., and Fuhrman B. Pomegranate juice flavonoids inhibit LDL oxidation and cardiovascular diseases: studies in atherosclerotic mice and in humans. In: Colic M., Pavelic K., and Seitz H.J. (Eds). ICMAN Proceedings (2002), Bioscience Ediprint 49-62
2. Rice-Evans C.A., Miller N.J., Bolwell P.G., Bramley P.M., and Pridham J.B. The relative antioxidant activities of plant-derived polyphenolic flavonoids. Free Radic. Res. 22 (1995) 375-383
3. Rice-Evans C.A., Miller N.J., and Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic. Biol. Med. 20 (1996) 933-956
4. van Acker S.A., van den Berg D.J., Tromp M.N., Griffioen D.H., van Bennekom W.P., van der Vijgh W.J., and Bast A. Structural aspects of antioxidant activity of flavonoids. Free Radic. Biol. Med 20 (1996) 331-342
5. Langley P. Why a pomegranate?. Br. Med. J. 321 (2000) 1153-1154
6. Aviram M. Polyphenols from pomegranate juice, red wine, and licorice root protect against lipids peroxidation and attenuate cardiovascular diseases. In: Martens S., Treutter D., and Forkmann G. (Eds). "Polyphenols 2000." Proc. XX Int. Conf. Polyphenols (2002), Freising-Weihenstephan, Freising 158-175
7. Heftaman E., and Bennett S.T. Identification of estrone in pomegranate seeds. Phytochemistry 5 (1966) 1337-1340
8. Moneam N.M., El Sharasky A.S., and Badreldin M.M. Oestrogen content of pomegranate seeds. J. Chromatogr. 438 (1988) 438-442
9. Sharaf A., and Nigm S.A. The oestrogenic activity of pomegranate seed oil. J. Endocrinol. 29 (1964) 91-92
10. Gil M.I., Tomas-Barberan F.A., Hess-Pierce B., Holcroft D.M., and Kader A.A. Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. J. Agric. Food Chem. 48 (2000) 4581-4589
11. Ignarro L.J. Introduction and overview. In: Ignarro L.J. (Ed). Nitric Oxide Biology and Pathobiology (2000), Academic Press, San Diego 3-19
12. de Nigris F., Lerman A., Ignarro L.J., Williams-Ignarro S., Sica V., Baker A.H., Lerman L.O., Geng Y.J., and Napoli C. Oxidation-sensitive mechanisms, vascular apoptosis and atherosclerosis. Trends Mol. Med. 9 (2003) 351-359
13. Ignarro L.J., Cirino G., and Napoli C. Nitric oxide as a signaling molecule in the vascular system: an overview. J. Cardiovasc. Pharmacol. 34 (1999) 879-886
14. Napoli C., and Ignarro L.J. Nitric oxide and atherosclerosis. Nitric Oxide 5 (2001) 88-97
15. de Nigris F., Lerman L.O., Williams-Ignarro S., Sica G., Lerman A., Palinski W., Ignarro L.J., and Napoli C. Beneficial effects of antioxidants and l-arginine on oxidation-sensitive gene expression and endothelial NO synthase activity at sites of disturbed shear stress. Proc. Natl. Acad. Sci. USA 100 (2003) 1420-1425
16. Ignarro L.J., and Napoli C. Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis. Curr. Atheroscler. Rep. 6 (2004) 281-287
17. Boger R.H., and Bode-Boger S.M. The clinical pharmacology of l-arginine. Annu. Rev. Pharmacol. Toxicol. 41 (2001) 79-99
18. Cooke J.P. Flow, NO, and atherogenesis. Proc. Natl. Acad. Sci. USA 100 (2003) 768-770
19. Boger R.H., Bode-Boger S.M., Mugge A., Kienke S., Brandes R., Dwenger A., and Frolich J.C. Supplementation of hypercholesterolemic rabbits with l-arginine reduces the vascular release of superoxide anions and restores NO production. Atherosclerosis 117 (1995) 273-284
20. McNamara D.B., Bedi B., Aurora H., Tena L., Ignarro L.J., Kadowitz P.J., and Akers D.L. l-Arginine inhibits balloon catheter-induced intimal hyperplasia. Biochem. Biophys. Res. Commun. 193 (1993) 291-296
21. Cooke J.P., Singer A.H., Tsao P.S., Zera P., Rowan R.A., and Billingham M.E. Antiatherogenic effects of l-arginine in the hypercholesterolemic rabbit. J. Clin. Invest. 90 (1992) 1168-1172
22. Wang B.Y., Singer A.H., Tsao P.S., Drexler H., Kosek J., and Cooke J.P. Dietary arginine prevents atherogenesis in the coronary artery of the hypercholesterolemic rabbit. J. Am. Coll. Cardiol. 23 (1994) 452-458
23. Boger R.H., Bode-Boger S.M., Kienke S., Stan A.C., Nafe R., and Frolich J.C. Dietary l-arginine decreases myointimal cell proliferation and vascular monocyte accumulation in cholesterol-fed rabbits. Atherosclerosis 136 (1998) 67-77
24. Napoli C., Williams-Ignarro S., de Nigris F., Lerman L.O., Rossi L., Guarino C., Mansueto G., Di Tuoro F., Pignalosa O., De Rosa G., Sica V., and Ignarro L.J. Long-term combined beneficial effects of physical training and metabolic treatment on atherosclerosis in hypercholesterolemic mice. Proc. Natl. Acad. Sci. USA 101 (2004) 8797-8802
25. Boger R.H., Bode-Boger S.M., Thiele W., Creutzig A., Alexander K., and Frolich J.C. Restoring vascular nitric oxide formation by l-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease. J. Am. Coll. Cardiol. 32 (1998) 1336-1344
26. Ignarro L.J., Buga G.M., Wei L.H., Bauer P.M., Wu G., and del Soldato P. Role of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferation. Proc. Natl. Acad. Sci. USA 98 (2001) 4204-4208
27. C. Napoli, F. de Nigris, S. Williams-Ignarro, O. Pignalosa, V. Sica, L.J. Ignarro, Nitric oxide and atherosclerosis: novel therapeutical challenges, Br. J. Pharmacol., in press.
28. de Nigris F., Williams-Ignarro S., Lerman L.O., Crimi E., Botti C., Mansueto G., D'Armiento F.P., De Rosa G., Sica V., and Ignarro L.J. Beneficial effects of pomegranate juice on oxidation-sensitive genes and endothelial nitric oxide synthase activity at sites of perturbed shear stress. Proc. Natl. Acad. Sci. USA 102 (2005) 4896-4901
29. Hobbs A.J., Fukuto J.M., and Ignarro L.J. Formation of free nitric oxide from l-arginine by nitric oxide synthase: direct enhancement of generation by superoxide dismutase. Proc. Natl. Acad. Sci. USA 91 (1994) 10992-10996
30. Bush P.A., Gonzalez N.E., Griscavage J.M., and Ignarro L.J. Nitric oxide synthase from cerebellum catalyzes the formation of equimolar quantities of nitric oxide and citrulline from l-arginine. Biochem. Biophys. Res. Commun. 185 (1992) 960-966
31. Keefer L.K., Nims R.W., Davies K.M., and Wink D.A. "NONOates" (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms. Methods Enzymol. 268 (1996) 281-293
32. Wei L.H., Wu G., Morris Jr. S.M., and Ignarro L.J. Elevated arginase I expression in rat aortic smooth muscle cells increases cell proliferation. Proc. Natl. Acad. Sci. USA 98 (2001) 9260-9264
33. Wallerath T., Li H., Godtel-Ambrust U., Schwarz P.M., and Forstermann U. A blend of polyphenolic compounds explains the stimulatory effect of red wine on human endothelial NO synthase. Nitric Oxide 12 (2005) 97-104
34. Zou J.G., Wang Z.R., Huang Y.Z., Cao K.J., and Wu J.M. Effect of red wine and wine polyphenol resveratrol on endothelial function in hypercholesterolemic rabbits. Int. J. Mol. Med. 11 (2003) 317-320
35. Bauer P.M., Buga G.M., Fukuto J.M., Pegg A.E., and Ignarro L.J. Nitric oxide inhibits ornithine decarboxylase via S-nitrosylation of cysteine 360 in the active site of the enzyme. J. Biol. Chem. 276 (2001) 34458-34464
36. wafl/cipl in the regulation of vascular smooth muscle cell proliferation by nitric oxide. Proc. Natl. Acad. Sci. USA 98 (2001) 12802-12807
37. Ross R. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340 (1999) 115-126
38. Cooke J.P. Is atherosclerosis an arginine deficiency disease?. J. Investig. Med. 46 (1998) 377-380
39. Hayashi T., Ishikawa T., Naito M., Kuzuya M., Funaki C., Asai K., Hidaka H., and Kuzuya F. Low level hyperlipidemia impairs endothelium-dependent relaxation of porcine coronary arteries by two mechanisms. Functional change in endothelium and impairment of endothelium-dependent relaxation by two mediators. Atherosclerosis 87 (1991) 23-38
40. Kauser K., da Cunha V., Fitch R., Mallari C., and Rubanyi G.M. Role of endogenous nitric oxide in progression of atherosclerosis in apolipoprotein E-deficient mice. Am. J. Physiol. 278 (2000) H1679-H1685
41. Ignarro L.J., Cirino G., Casini A., and Napoli C. Nitric oxide as a signaling molecule in the vascular system: an overview. J. Cardiovasc. Pharmacol. 34 (1999) 879-886
42. Diaz M.N., Frei B., Vita J.A., and Keaney Jr. J.F. Antioxidants and atherosclerotic heart disease. N. Engl. J. Med. 337 (1997) 408-416
43. Boger R.H., Bode-Boger S.M., Phivthong-ngam L., Brandes R.P., Schwedhelm E., Mugge A., Bohme M., Tsikas D., and Frolich J.C. Dietary l-arginine and alpha-tocopherol reduce vascular oxidative stress and preserve endothelial function in hypercholesterolemic rabbits via different mechanisms. Atherosclerosis 141 (1998) 31-43
44. Napoli C., Ackah E., De Nigris F., del Soldato P., D'Armiento F.P., Crimi E., Condorelli M., and Sessa W.C. Chronic treatment with nitric oxide-releasing aspirin reduces plasma low-density lipoprotein oxidation and oxidative stress, arterial oxidation-specific epitopes, and atherogenesis in hypercholesterolemic mice. Proc. Natl. Acad. Sci. USA 99 (2002) 12467-12470
45. Fuhrman B., and Aviram M. Anti-atherogenicity of nutritional antioxidants. Drugs 4 (2001) 82-92
46. Hertog M.G., Kromhout D., Aravanis C., Blackburn H., Buzina R., Fidanza F., Giampaoli S., Jansen A., Menotti A., and Nedeljkovic S. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch. Intern. Med. 155 (1995) 381-386
47. Aviram M., and Dornfeld L. Pomegranate juice consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure. Atherosclerosis 158 (2001) 195-198